QuickView for negative adaptation of signaling pathway (biogroup)

1. L1000 CMAP - Hepatocellular carcinoma HEPG2 cells treated with small molecule perturbagens
2. Drug Matrix In Vivo Toxicogenomic Study - Rat Bone Marrow [Codelink]
3. L1000 CMAP - Kidney epithelial HA1E.311 cells with CRISPR targeted gene knockouts
4. L1000 CMAP - Breast adenocarcinoma SKBR3 cells treated with small molecule perturbagens
5. L1000 CMAP - Neuronal NEU cells treated with small molecule perturbagens

There were no matches for negative adaptation of signaling pathway

1. "ADAPT" The Adaptation to High Fat Diets Extention
2. Trametinib for Pediatric Neuro-oncology Patients With Refractory Tumor and Activation of the MAPK/ER…
3. Ibrutinib Adapted to Response in Patients With CLL
4. Impact of Inflammation on Reward Circuits, Motivational Deficits and Negative Symptoms in Schizophre…
5. Personalized Risk-Adapted Therapy in Post-Pubertal Patients With Newly-Diagnosed Medulloblastoma